BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 4, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 7, 2008
View Archived Issues
The low-molecular-weight thiol pantethine confers protection against cerebral malaria
Read More
Shigella gastroenteritis vaccine immunogenic in phase I study
Read More
Salsalate reduces glycemia in obese subjects
Read More
ReNeuron schedules meeting with FDA to resolve IND hold for ReN-001
Read More
Penwest announces results of a phase IIa clinical study of nalbuphine ER
Read More
Positive results reported for memantine once-daily formulation study
Read More
Statistical significance achieved in phase III studies for Puricase in gout
Read More
Patient recruitment completed in phase IIa clinical trial of KUR-212 for skin grafting
Read More
FDA extends PDUFA action date for GSK's Requip XL for Parkinson's disease
Read More
Generex selects 72 clinical centers to participate in phase III study of Oral-lyn
Read More
Vaxine completes recruitment for phase I/II clinical trial of influenza vaccine
Read More
mtm Laboratories launches Cervatec assay for cervical cancer
Read More
GTC reports data from a pivotal study of ATryn for hereditary antithrombin deficiency
Read More
Recent patents report new therapeutic agents for obesity and lipoprotein disorders
Read More
Epistem and AstraZeneca report results from preliminary study of human hair biomarker technology
Read More
FDA supports favorable risk-benefit profile for Luitpold's Injectafer
Read More
Novel agents for psychological disorders disclosed in recent patent literature
Read More
Recent AstraZeneca patent describes novel antiarrhythmia agents
Read More
Promising antitumor effects with novel anti-HAAH antibody in preclinical studies
Read More
TorreyPines reports results from phase I clinical trial of tezampanel for chronic pain
Read More
Immunomedics announces results from phase I/II clinical trial of veltuzumab
Read More
Astex receives IND approval for Hsp90 inhibitor AT-13387
Read More
7TM Pharma selects new preclinical candidate for obesity and type 2 diabetes
Read More
Biovitrum and Symphogen complete phase I recombinant polyclonal antibody trial
Read More
Intercell's HCV vaccine meets primary endpoints in phase II clinical studies
Read More
Positive results reported from Nymox's U.S. study of NX-1207 for BPH
Read More